【ChiCTR2100044537】SHOCK INDEX AS A PROGNOSTICATOR FOR EMERGENT SURGICAL INTERVENTION AND MORTALITY IN TRAUMA PATIENTS AT A TERTIARY HOSPITAL IN JOHANNESBURG: A MEDICAL RECORDS BASED RETROSPECTIVE COHORT REVIEW
ChiCTR2100044537
结束
/
/
/
2021-03-23
/
/
Trauma
SHOCK INDEX AS A PROGNOSTICATOR FOR EMERGENT SURGICAL INTERVENTION AND MORTALITY IN TRAUMA PATIENTS AT A TERTIARY HOSPITAL IN JOHANNESBURG: A MEDICAL RECORDS BASED RETROSPECTIVE COHORT REVIEW
SHOCK INDEX AS A PROGNOSTICATOR FOR EMERGENT SURGICAL INTERVENTION AND MORTALITY IN TRAUMA PATIENTS AT A TERTIARY HOSPITAL IN JOHANNESBURG: A MEDICAL RECORDS BASED RETROSPECTIVE COHORT REVIEW
To describe the demographics (Age, Gender, Population group) of patients presenting to the Trauma Unit. To describe the mechanism of injury (blunt/penetrating) of patients presenting to the Trauma Unit and their relationship to SI. To describe the distribution of anatomical regions and initial physiological parameters of injuries in terms of Injury Severity scores. To evaluate the relationship between the SI and need for emergent surgical intervention To describe the type of emergent surgical intervention performed. To describe the relationship between SI and in-hospital mortality.
连续入组
回顾性研究
N/A
N/A
Private
/
1523
/
2018-11-01
2021-02-01
/
All records of patients over the age of 18 years old who were trauma team activations；
请登录查看Patients declared Dead on Arrival or whose injuries are deemed non-survivable; All isolated Traumatic Brain Injury (TBI) patients and Isolated Thermal/Chemical Injuries; All patients taken for surgery for isolated Orthopaedic procedures where by the procedure is not related to the control of haemorrhage; Patients whose physiological response to hypovolemia will be altered such as those known to be on rate control medications / pace makers or started on inotropes prior to hospital admission; Patients referred in from another hospital; Patients discharged / who sign refusal of hospital treatment or abscond without admission to the unit for further treatment.；
请登录查看Dr Richard Allan Crawford
/
Dr Richard Allan Crawford的其他临床试验
南非约翰内斯堡University of Witwatersrand的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示：#脐带间充质干细胞（#hUC-MSCs）
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点，索弗度肽（survodutide）成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构：国家卫生健康委办公厅、 2026-11-10
-
颁布机构：国家卫健委（原国家卫计委） 2026-11-10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-04